Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1717947

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that NHS medical staff are made aware of a patient's personalised care plan.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	26189
answer	answer is ministerial correction date of answer 24/05/2024 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 24/05/2024 13:59:41 answering member 4527 label Biography information for Helen Whately
tabling member	4571 label Biography information for Gill Furniss

1717948

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sickle Cell Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department has taken to improve awareness of sickle cell disease among healthcare professionals.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	26190
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>The Government is committed to improving the lives of those living with rare diseases such as sickle cell disease, and published the UK Rare Diseases Framework in January 2021, providing the high-level approach for rare diseases. The framework outlines future priorities including increasing awareness of rare diseases among healthcare professionals. In England we publish action plans annually to address these priorities. As part of this plan we committed to developing an innovative digital educational resource, ‘GeNotes’, providing healthcare professionals with relevant and concise information to support patient management, linking to the NHS Genomic Test Directories, and signposting to extended learning opportunities. This resource includes information on sickle cell disease and is updated regularly.</p><p>There have been recent improvements to the haematology medical curriculum, with understanding sickle cell disease now described in the curriculum as a core competency. The National Healthcare Inequalities Improvement Programme has launched several products to support NHS England in raising awareness of sickle cell disease among healthcare professionals including NHS England’s Can you tell it's Sickle Cell campaign and e-learning module and a communications campaign to raise awareness of existing NHS England arrangements to support people with sickle cell disease to save money on the costs of regular prescriptions.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 14:17:22 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4571 label Biography information for Gill Furniss

1717980

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Attention Deficit Hyperactivity Disorder: Suffolk
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the adequacy of the availability of NHS provision for the diagnosis and treatment of ADHD in Suffolk.
tabling member constituency	Suffolk Coastal
tabling member printed	Dr Thérèse Coffey
uin	26130
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including access to assessment and treatment for attention deficit hyperactivity disorder (ADHD), in line with relevant National Institute for Health and Care Excellence (NICE) guidance. The NICE guideline on ADHD does not recommend a maximum waiting time from referral for an assessment of ADHD to the point of assessment or diagnosis.</p><p>Whilst the Department has not made a specific assessment, Suffolk and North East Essex ICB advises that it has undertaken a review of children’s ADHD and autism services. As a result of the review, and current demand, the ICB has agreed additional funding of £3.3 million to support the services to not only reduce the time children are waiting for assessment but also increase the service provision to meet future demand. The ICB is also looking at potential new models of delivery and at the current pathways to see how it can utilise them more efficiently to ensure a smoother process for families.</p><p>In respect of adult ADHD and autism services, the ICB has worked closely with its local National Health Service provider, Norfolk and Suffolk NHS Foundation Trust, to closely monitor and respond to increases in demand. In March 2024, the ICB agreed to invest £300,000 to support those patients on the waiting list with additional advice and support.</p><p>In respect of the adequacy of ADHD service provision nationally, in December 2023, NHS England initiated a rapid piece of work to consider ADHD service provision within the NHS. The initial phase of work identified challenges, including with current service models and the ability to keep pace with demand. Following this initial review, NHS England is establishing a new ADHD taskforce alongside the government, to look at ADHD service provision and its impact on patient experience. The new taskforce will bring together expertise from across a broad range of sectors, including the NHS, education and justice, to better understand the challenges affecting people with ADHD and help provide a joined-up approach in response to concerns around rising demand.</p><p>Alongside the work of the taskforce, NHS England has announced that it will continue to work with stakeholders to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape and capture examples from local health systems which are trialling innovative ways of delivering ADHD services to ensure best practice is captured and shared across the system.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/05/2024 09:50:20 answering member 4492 label Biography information for Maria Caulfield
tabling member	4098 label Biography information for Dr Thérèse Coffey

1717990

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Suffolk Coastal
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many additional NHS dental appointments have been made available for patients as a result of the Dental Recovery Plan in Suffolk Coastal constituency.
tabling member constituency	Suffolk Coastal
tabling member printed	Dr Thérèse Coffey
uin	26140
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>Our Dentistry Recovery Plan, backed by £200 million, will make dental services faster, simpler, and fairer for National Health Service dental patients. It will fund approximately 2.5 million additional appointments, or more than 1.5 million additional courses of dental treatment. A New Patient Premium is supporting dentists to take on new patients, and since the end of January 2024, nearly 500 more practices have said they are open to new patients.</p><p>We are committed to evaluating the impacts of the measures included in our plan, and we will publish monthly data on progress once available. Dentists have two months from the date of completion of a course of NHS treatment to submit an FP17 claim for payment.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 22/05/2024 15:09:26 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4098 label Biography information for Dr Thérèse Coffey

1717991

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ambulance Services: Suffolk
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce ambulance waiting times in (a) Suffolk and (b) Suffolk Coastal constituency.
tabling member constituency	Suffolk Coastal
tabling member printed	Dr Thérèse Coffey
uin	26141
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>Our Delivery plan for recovering urgent and emergency care services sets out the range of measures being taken to achieve our ambition of reducing average Category 2 ambulance response times to 30 minutes across 2024/25, including in Suffolk. A summary of the progress made, and actions taken in 2024/25 is set out in Urgent and emergency care recovery plan year 2: building on learning from 2023/24, which is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/urgent-and-emergency-care-recovery-plan-year-2-building-on-learning-from-2023-24/" target="_blank">https://www.england.nhs.uk/publication/urgent-and-emergency-care-recovery-plan-year-2-building-on-learning-from-2023-24/</a></p><p>Nationally, ambulance trusts received £200 million of additional funding in 2023/24 to increase deployed hours and reduce response times, and this service capacity is being maintained in 2024/25. This is alongside the delivery of new ambulances, and action to reduce handover delays. With more ambulances on the roads, patients will receive the treatment they need more swiftly.</p><p>Since we published our plan, there has been significant improvement in ambulance response times, including in Suffolk. In 2023/24, average Category 2 ambulance response time in the East of England was over 23 minutes faster compared to the previous year, a reduction of over 34%.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 20/05/2024 17:00:19 answering member 4527 label Biography information for Helen Whately
tabling member	4098 label Biography information for Dr Thérèse Coffey

1718014

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Whooping Cough: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase the vaccination rates for whooping cough.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	26088
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>The whooping cough, also known as pertussis, vaccine is offered antenatally. As part of best practice, NHS England vaccinates pregnant women opportunistically during maternity appointments. Information materials are available across antenatal and primary care settings to increase vaccination rates for pertussis during pregnancy. NHS England will also implement the National Health Service vaccination strategy, building on the success of the COVID-19 vaccine programme, to find innovative ways to reach people.</p><p>A recent national marketing campaign reminded parents to check their children’s vaccination status, and stressed the importance of getting vaccinated for pregnant women, infants, and children. A second phase of the campaign is due to begin around mid-summer 2024. Whooping cough and maternal vaccine uptake awareness will be raised with clinicians and key royal colleges through targeted clinical and epidemiological updates, and supportive communications. There will also be engagement with local communities to highlight the importance of vaccination, and how to access the vaccine.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/05/2024 09:38:37 answering member 4492 label Biography information for Maria Caulfield
tabling member	1447 label Biography information for Andrew Rosindell

1718033

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prostate Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what her steps her Department is taking to improve early diagnosis rates for prostate cancer prior to the TRANSFORM trial findings.
tabling member constituency	Ipswich
tabling member printed	Tom Hunt
uin	26279
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Improving early diagnosis of cancer, including prostate cancer, remains a priority for the Government and we are working towards the NHS Long Term Plan ambition of diagnosing 75% of stageable cancers at stage 1 and 2 by 2028. We know more people are surviving cancer in the United Kingdom than ever and that is partly down to early diagnosis.</p><p>Prior to the TRANSFORM trial, we are helping more people get diagnosed earlier by raising awareness, implementing the faster diagnosis standard and funding investment in research and diagnostics. NHS England takes steps to raise awareness of prostate cancer where there are opportunities to do so; for example NHS England partners with cancer alliances, charities and local representatives to reach people through projects in the heart of their communities. Cancer alliances have also been undertaking action to alert ‘at risk’ groups about prostate cancer, this is determined at a local level and so will vary depending on local needs and priorities.</p><p>To support faster diagnosis, NHS England is streamlining cancer pathways and in October 2022 introduced the best practice timed pathway for prostate cancer. This guidance recommends those with suspected prostate cancer undertake a multi-parametric magnetic resonance imaging (MRI) before biopsy, which ensures only those men most at risk of having cancer undergo an invasive biopsy.</p><p>In 2018, the Government announced £75 million of funding for clinical trials for prostate cancer, focusing on early diagnosis, survival rates and treatment options. Since April 2018, the National Institute for Health and Care Research (NIHR) has awarded over £60 million to more than 28 research studies relevant to prostate cancer. These include randomised controlled trials of different treatments, a randomised controlled trial of different methods of biopsy and a survivors’ rehabilitation evaluation.</p><p>Alongside cutting-edge research, we are helping more people get diagnosed earlier for cancer and other conditions by rolling out additional tests, checks and scans at 160 locations across England through our Community Diagnostics Centres programme.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 16:46:06 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4771 label Biography information for Tom Hunt

1718034

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coeliac Disease: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which part of NHS England has accountability for coeliac disease diagnoses.
tabling member constituency	Watford
tabling member printed	Dean Russell
uin	26290
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>Integrated care boards (ICB) commission services to meet the needs of their local populace. Diagnosis of coeliac disease falls within the portfolio of ICB-commissioned services. As such, NHS England does not have central accountability. However, NHS England has invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme.</p><p>The diagnosis of coeliac disease commonly involves a blood test and, in some cases, a biopsy of the small intestine. Post-diagnosis, further blood tests, which check the levels of iron and other vitamins and minerals, may be required to assess how the condition has affected the individual, such as the potential for iron deficiency anaemia due to poor absorption of nutrients. A bone density scan may also be recommended if the condition is thought to affect the individual’s bones.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 14:05:34 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4812 label Biography information for Dean Russell

1718037

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department (a) is taking and (b) plans to take to help (i) facilitate and (ii) increase the voluntary uptake of the shingles vaccine by people aged 66 to 69 in (A) Southport and (B) the UK.
tabling member constituency	Southport
tabling member printed	Damien Moore
uin	26248
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>The current policy offers the shingles vaccine Shingrix to anyone who turned 65 or 70 years old on or after 1 September 2023, and to anyone aged 50 years old and over, which includes those aged 66 to 69 years old, who is at higher risk of serious complications as a result of having a severely weakened immune system, and who has been prioritised for vaccination by the National Health Service.</p><p>Healthy 66 to 69 year olds who do not have a severely weakened immune system are not currently eligible to receive the shingles vaccine, although they will become eligible when they turn 70 years old, as they would have done prior to 1 September 2023.</p><p>The UK Health Security Agency (UKHSA) provides public facing information, including translations into over 20 different languages, including braille, audio, large print, and British Sign Language, to help increase the uptake of the shingles vaccine and information for healthcare professionals.</p><p>Decisions regarding eligibility and the design of the current programme roll-out are based on clinical advice, including the independent advice of the Joint Committee on Vaccination and Immunisation, and follow a similar pattern to the 2013 roll-out of the single dose shingles vaccine. However, the Government recognises the concerns of those currently aged 65 to 69 and is looking at ways to improve our approach. This includes options for working with NHS England and the UKHSA to enhance the way in which eligibility for this immunisation is communicated to the public, but also considers potential wider changes.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/05/2024 16:13:09 answering member 4492 label Biography information for Maria Caulfield
tabling member	4669 label Biography information for Damien Moore

1718038

registered interest
date	14/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coeliac Disease: National Clinical Directors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of appointing a National Clinical Director within NHS England for coeliac disease.
tabling member constituency	Southport
tabling member printed	Damien Moore
uin	26249
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>NHS England has invested in senior clinical leadership in gastroenterology, which includes coeliac disease, as a priority workstream in the national Getting It Right First Time programme.</p><p>To support healthcare professionals in the diagnosis and management of coeliac disease, and improve the diagnostic pathway nationally, the National Institute for Health and Care Excellence (NICE) has produced the guidance, Coeliac disease: recognition, assessment and management [NG20].</p><p>NICE guidelines represent best practice, and both healthcare professionals, including general practitioners, and service commissioners are expected to take them fully into account. Guidelines published by the NICE are not mandatory, and do not replace the judgement of clinicians in determining the most appropriate treatment for individual patients.</p><p>To assist with increasing the visibility of coeliac disease, the NICE promotes guidance via its website, newsletters, and other media. It also publishes information for the public, which explains the care people with coeliac disease should receive, as set out in the NICE guideline. Information for the public on coeliac disease is also published by the National Health Service and is available on the NHS website.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 14:17:27 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4669 label Biography information for Damien Moore